Sickle Cell Anemia*

Periodontal Disease*

 

AntiMalarial*

 

Pancreatic Cancer*

 

Opioid Addiction Relapse*

*Inquisitex Epitherapeutics has not acquired any rights to these technologies owned by the Medical University of South Carolina (MUSC) or MUSC affiliates. Inquisitex Epitherapeutics employees are involved with research on these technologies as part of their duties as MUSC employees.